Results 161 to 170 of about 4,931,245 (245)

Possible Improvement of Tardive Dyskinesia and Negative Symptoms With Lurasidone Augmentation in a Treatment-Resistant Schizophrenia Patient. [PDF]

Case Rep Psychiatry
Günay U, Demiröz C, Kocaayan FS, Dalkıran İ, Tatlıdil E.   +4 more
europepmc   +1 more source

Time zero alignment in target trial emulation of VMAT2 inhibitors versus anticholinergics for tardive dyskinesia. [PDF]

Psychiatry Clin Neurosci
Matsuda Y, Suzuki Y.
europepmc   +1 more source

Levodopa exacerbated tremor in Parkinson's disease. [PDF]

Front Neurol
Baizabal-Carvallo JF, Alonso-Juarez M, Fekete R.   +2 more
europepmc   +1 more source

Acute Onset Extrapyramidal Symptoms With Clozapine: A Report of a Rare Case. [PDF]

Cureus
Nandakumar S, Ramdurg S, Chaukimath S, Kalasagond MB, S G G.   +4 more
europepmc   +1 more source

Letter: Clonazepam in the treatment of drug-induced dyskinesia. [PDF]

BMJ, 1975
openaire   +2 more sources

Amantadine-induced livedo reticularis. [PDF]

CMAJ
Shima A, Yoshikawa S, Ueda T.
europepmc   +1 more source

Indirect Striatal Projection Neurons Drive a D2 Receptor-Dependent Pathway to Dyskinesia and Dystonia. [PDF]

Mov Disord
Andreoli L, Nyman T, Espa E, Jakobsson J, Elabi OF, Cenci MA.   +5 more
europepmc   +1 more source

Long-Term Surgical Outcomes and Influential Factors of Subthalamic Nucleus Deep Brain Stimulation for Dyskinesia in Parkinson's Disease: A 3-Year Longitudinal Cohort Study. [PDF]

Clin Interv Aging
Wang S, Xue T, Ma R, Shi L, Zhu G, Jiang Y, Yang A, Meng F, Zhang J.   +8 more
europepmc   +1 more source

Serum ferritin, neutrophil-to-lymphocyte ratio, and lymphocyte-to-monocyte ratio are associated with levodopa-induced dyskinesia severity in Parkinson's disease. [PDF]

BMC Neurol
Saidvaliyev F, Pulatova D, Kilichev I, Yusupov A, Shamuratova G, Turdibekov X, Pulatov M, Saidov J, Mirhayotova N, Axmedova Y, Abdullayeva D.   +10 more
europepmc   +1 more source

Natural Frequencies of Levodopa-Induced Dyskinesia in Parkinson's Disease. [PDF]

Ann Clin Transl Neurol
Isaias IU, Avantaggiato F, Pezzoli G, Canessa A.   +3 more
europepmc   +1 more source